Literature DB >> 4014206

Antibodies to delta antigen in asymptomatic hepatitis B surface antigen-reactive blood donors in the United States and their association with other markers of hepatitis B virus.

N Nath, I K Mushahwar, C T Fang, H Berberian, R Y Dodd.   

Abstract

A total of 1,915 sera collected in 1979 from asymptomatic hepatitis B surface antigen (HBsAg) carriers were tested for delta antigen, antibody to delta antigen (anti-delta), hepatitis B e antigen (HBeAg) and antibody to hepatitis B e antigen (anti-HBe) in addition to HBsAg and its subtypes. These sera represented blood donated by volunteers to 49 of 57 regions of the American Red Cross located in nine geographic regions of the United States and Puerto Rico. A total of 72 (3.8%) sera had anti-delta activity while none had a detectable level of delta antigen. A significantly higher (p less than 0.01) prevalence of anti-delta (12.1%) was found in San Jose, California (Pacific Region); on the other hand, the East South Central region covering Alabama, Kentucky, Mississippi and Tennessee had a significantly lower (p less than 0.05) prevalence (1.4%) of anti-delta when compared with all other regions combined. Anti-delta was, however, detected in all regions of the United States and in Puerto Rico. The cause of significant differences in the prevalence of anti-delta was not clear. The distribution of anti-delta was not associated with age, sex or blood type of the donor. Sixty-nine of 70 samples with anti-delta were found among the 1,527 samples that had either HBeAg or anti-HBe. And among 149 that lacked both HBeAg and anti-HBe, only one sample had anti-delta. The difference is statistically significant (p less than 0.05). The presence of anti-delta was not associated with HBsAg/ad (2.7%) or HBsAg/ay (4.6%).

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4014206     DOI: 10.1093/oxfordjournals.aje.a114092

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  9 in total

Review 1.  Epidemiology, Natural History, and Treatment of Hepatitis Delta Virus Infection in HIV/Hepatitis B Virus Coinfection.

Authors:  Nicole D Ferrante; Vincent Lo Re
Journal:  Curr HIV/AIDS Rep       Date:  2020-08       Impact factor: 5.071

2.  Prevalence of delta agent infection in Canada.

Authors: 
Journal:  CMAJ       Date:  1986-02-15       Impact factor: 8.262

Review 3.  Hepatitis delta virus: Making the point from virus isolation up to 2014.

Authors:  Raffaella Romeo; Riccardo Perbellini
Journal:  World J Hepatol       Date:  2015-10-08

4.  Prevalence, correlates, and viral dynamics of hepatitis delta among injection drug users.

Authors:  Lauren M Kucirka; Homayoon Farzadegan; Jordan J Feld; Shruti H Mehta; Mark Winters; Jeffrey S Glenn; Gregory D Kirk; Dorry L Segev; Kenrad E Nelson; Morgan Marks; Theo Heller; Elizabeth T Golub
Journal:  J Infect Dis       Date:  2010-09-15       Impact factor: 5.226

Review 5.  Delta hepatitis: molecular biology and clinical and epidemiological features.

Authors:  L B Polish; M Gallagher; H A Fields; S C Hadler
Journal:  Clin Microbiol Rev       Date:  1993-07       Impact factor: 26.132

6.  Lack of evidence of hepatitis D (delta) infection in Newfoundland and Labrador.

Authors:  S Ratnam; C B Head; R W Butler
Journal:  CMAJ       Date:  1986-04-15       Impact factor: 8.262

7.  Delta hepatitis in Denver.

Authors:  W G Rector; S Govindarajan; K A Penley; F N Judson
Journal:  West J Med       Date:  1988-07

8.  ABO blood groups and hepatitis B virus infection: a systematic review and meta-analysis.

Authors:  Wenzhan Jing; Siyu Zhao; Jue Liu; Min Liu
Journal:  BMJ Open       Date:  2020-02-02       Impact factor: 2.692

9.  Risk Factors for Delta Hepatitis in a North American Cohort: Who Should Be Screened?

Authors:  Ben L Da; Farial Rahman; Walter C Lai; David E Kleiner; Theo Heller; Christopher Koh
Journal:  Am J Gastroenterol       Date:  2021-01-01       Impact factor: 12.045

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.